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Abstract
Changes in Dengue virus (DENV) disease patterns in the Americas over recent decades have been attributed, at least in
part, to repeated introduction of DENV strains from other regions, resulting in a shift from hypoendemicity to
hyperendemicity. Using newly sequenced DENV-1 and DENV-3 envelope (E) gene isolates from 11 Caribbean countries,
along with sequences available on GenBank, we sought to document the population genetic and spatiotemporal
transmission histories of the four main invading DENV genotypes within the Americas and investigate factors that
influence the rate and intensity of DENV transmission. For all genotypes, there was an initial invasion phase characterized
by rapid increases in genetic diversity, which coincided with the first confirmed cases of each genotype in the region. Rapid
geographic dispersal occurred upon each genotype’s introduction, after which individual lineages were locally maintained,
and gene flow was primarily observed among neighboring and nearby countries. There were, however, centers of viral
diversity (Barbados, Puerto Rico, Colombia, Suriname, Venezuela, and Brazil) that were repeatedly involved in gene flow
with more distant locations. For DENV-1 and DENV-2, we found that a ‘‘distance-informed’’ model, which posits that the
intensity of virus movement between locations is inversely proportional to the distance between them, provided a better
fit than a model assuming equal rates of movement between all pairs of countries. However, for DENV-3 and DENV-4, the
more stochastic ‘‘equal rates’’ model was preferred.
Key words: dengue virus, gene flow, Bayesian phylogeography, Americas, population dynamics, evolution, coalescent.
Introduction
Dengue virus (DENV) is the most widely distributed
flavivirus species, found in almost all tropical and subtropical
regions where the mosquito vectors Aedes aegypti and Ae-
des albopictus thrive (Halstead 1992). This distribution pla-
ces approximately 2.5 billion people at risk of infection
(Guzman et al. 2010). DENV exists as four antigenically dis-
tinct serotypes (DENV-1 to DENV-4) that are further sub-
divided into numerous phylogenetically distinct genotypes.
All four serotypes are known to be the causative agents of
dengue fever and of the more severe dengue hemorrhagic
fever (DHF) and dengue shock syndrome (DSS). Dengue is
perhaps the most important emerging vector-borne dis-
ease of the 21st century. Recent figures estimate that there
are 50 million infections annually, including 500,000 hospi-
talizations due to DHF alone (Guzman et al. 2010), and
since the 1980s, there has been a 4.5-fold increase in the
number of reported cases Americas alone (San Martin
et al. 2010).
Phylogenetic analyses suggest that currently circulating
serotypes diverged from their sylvatic ancestors approxi-
mately 1,000 years ago (Twiddy et al. 2003); however,
the geographic origins of DENV remain unclear and have
been alternatively attributed to Africa or Asia (Smith 1956;
Christophers 1960; Powell et al. 1980; Wang et al. 2000;
Diallo et al. 2005). Currently, the greatest genetic diversity
is found in Southeast Asia where all four serotypes have
been cocirculating since World War II (Gubler 2006). This
region has been identified as a source population for the
rapid and dramatic reemergence of DENV globally over the
last half-century, initially facilitated by the movement of
ships and goods during the Second World War (Gubler
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1997) and more recently by rapid increases in human pop-
ulation size, uncontrolled urbanization, and the advent of
rapid mass human movement (Gubler 1998; Kroeger and
Nathan 2006).
In the Americas, patients with dengue-like clinical symp-
toms were recorded as early as 1780 in Philadelphia (Rush
1789) but such outbreaks were rare. Before 1963, only
DENV-2 American genotype was reported in the Americas,
but since then the region has been subject to repeated in-
troductions (fig. 1). This shift from hypo- to hyperendemic-
ity was associated with a rise in the size and frequency of
DENV outbreaks (Gubler 1997). In addition, there was a rise
in DHF and DSS cases after the introduction of DENV-2
Asian–American genotype in 1981. Today, all four serotypes
exist in the Americas, and since 1963, the region has expe-
rienced outbreaks caused by at least one DENV-1 genotype,
two DENV-2 genotypes, three DENV-3 genotypes, and one
DENV-4 genotype (fig. 1).
There is a clear seasonality to DENV outbreaks in the
Americas, with peak incidence occurring when rainfall
and mosquito population densities are highest (Focks
and Barrera 2006; Halstead 2008). Although multiple sero-
types, and even multiple genotypes of a serotype, may be
detected in a given season, typically, a single serotype will
predominate regionally and to an even greater extent
within individual countries. At small epidemiological scales,
movement of DENV between locales has resulted in the
establishment of certain lineages within naive populations,
accompanied by the extinction of local circulating geno-
types (Zhang et al. 2005). Adams et al. (2006) investigated
the complex epidemic dynamics of all four serotypes in
Bangkok, Thailand, using an epidemic model with stochastic
seasonal forcing and found them to be characterized by 8- to
10-year epidemic oscillations. This dynamic was reflected in
DENV-1, DENV-2, and DENV-3 gene sequences collected
monthly over almost three decades. It was suggested that
moderate cross-protective immunity gave rise to persistent
out-of-phase epidemic oscillations among serotypes but that
strong or weak cross-protection/cross-enhancement only
produced in-phase patterns (Adams et al. 2006). Zhang
et al. (2005) proposed that the genetic diversity of a given
serotype increases at times of relative abundance of the
particular serotype and that hyperendemicity may lead to
complex patterns of selective competition, influenced by dif-
ferential susceptibility to cross-reactive host immunological
responses to cocirculating serotypes, genotypes, or lineages
within genotypes (Zhang et al. 2005).
Work done in the Caribbean, specifically in Puerto Rico
by Bennett et al. (2003, 2006), used epidemiological data
from passive surveillance to reveal similar DENV evolution-
ary dynamics among genotypes. In Puerto Rico, viral diver-
sity tends to be maintained in situ, driven by genetic drift
with notable clade extinction and replacement events over
time. Occasionally, new lineages are exchanged with South
and Central America and other regions in the Caribbean.
In the past, efforts have been made to infer the dispersal
of DENV and to elucidate the diffusion patterns of the virus
over decades (Carrington et al. 2005; Araujo et al. 2009).
However, these studies have been restricted to low-
resolution heuristic approaches that provide few insights
into the timescale of DENV spatial dynamics. Recently,
Lemey et al. (2009) introduced a Bayesian phylogeographic
inference framework, which incorporates the spatial and
temporal dynamics of viral lineages for inference, visualiza-
tion, and phylogeographic hypothesis testing. In this frame-
work, different scenarios and models of spatial spread can
be investigated and compared by specifying different prior
distributions for the diffusion rates among sampling locations
(Auguste et al. 2010; Talbi et al. 2010).
In this study, we have inferred the population dynamics
of DENV in the Americas and compared these with previ-
ously published results for DENV-2 and DENV-4 (Carrington
et al. 2005). We also undertook a thorough analysis of the
phylogeography of DENV in the Americas, which allowed us
to reconstruct the spatiotemporal spread of the virus and to
provide statistical assessment of the geographic locations of
ancestral infections. With these results, we also sought to
uncover the factors influencing the unique patterns of
FIG. 1. Timeline showing the introductions of the various genotypes of the four serotypes of DENV into the Americas. The flags of the countries
associated with the first reports are displayed. BRA, Brazil; CUBA, Cuba; DOM, Dominica; JAM, Jamaica; NIC, Nicaragua; PAN, Panama; PR,
Puerto Rico; and TRI, Trinidad and Tobago.
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population dynamics and spatial diffusion of DENV in the
Americas (Minin et al. 2008; Lemey et al. 2009).
Materials and Methods
Virus Isolation, Reverse Transcription Polymerase
Chain Reaction Amplification, and Nucleotide
Sequencing of Envelope (E) Gene
A total of 18 DENV-1 and 25 DENV-3 isolates from 10 Ca-
ribbean countries (see table 1) were obtained from the
Caribbean Epidemiology Centre (CAREC), Trinidad and To-
bago, where the viruses were isolated from sera by culturing
in C6/36 cells according to Tesh (1979). Viral RNA was ex-
tracted from 140 ll of cell culture supernatant using
QIAamp Viral RNA Mini Kits (Qiagen, Germany). Envelope
(E) genes were then amplified in a two-step process:
Reverse transcription was performed using SuperScript
III Reverse Transcriptase (Invitrogen) and amplified by
polymerase chain reaction (PCR) using PfuUltra II Fusion
HS DNA polymerase (Stratagene), using primers designed
for 2 coverage of the entire open reading frame (see
supplementary table S2, Supplementary Material online).
Amplicons were visualized on a 2% agarose gel and subse-
quently excised and purified using QIAquick Gel Extraction
kit (Qiagen). Purified PCR amplicons were sequenced at
the Greenwood Molecular Biology Facility, University of
Hawaii, HI. Sequences were assembled using Sequencher 4.5
(Gene Codes, Michigan) and were submitted to GenBank
under the accession numbers shown in table 1.
Data Sets
Derived DENV-1 and DENV-3 nucleotide sequences were
manually aligned together with previously published E gene
sequences from GenBank belonging to DENV-1 genotype V
and DENV-3 genotype III then trimmed to a common
length (see supplementary table S1, Supplementary
Table 1. DENV-1 and DENV-3 Sequences Derived from This Study.
Year Isolate Name Location Serotype Accession Number
1977 CAREC777882 Bahamas 1 JN379475
1977 CAREC778136 Grenada 1 JN379476
1977 CAREC778140 Grenada 1 JN379477
1977 CAREC778164 Grenada 1 JN379478
1977 CAREC778169 Grenada 1 JN379479
1977 CAREC778776 Grenada 1 JN379480
1978 CAREC780174 Grenada 1 JN379481
1978 CAREC780184 Grenada 1 JN379482
1981 CAREC817486 Trinidad and Tobago 1 JN379483
1981 CAREC817593 Grenada 1 JN379484
1981 CAREC817838 Suriname 1 JN379485
1995 CAREC9510153 Barbados 1 JN379486
1999 CAREC9911056 Barbados 1 JN379487
2001 CAREC0101764 Barbados 1 JN379470
2001 CAREC0101765 Barbados 1 JN379471
2003 CAREC0308216 Barbados 1 JN379472
2004 CAREC0403888 Aruba 1 JN379472
2005 CAREC0511227 Belize 1 JN379474
1998 CAREC 9810082 Jamaica 3 JN379502
1998 CAREC 9810095 Jamaica 3 JN379503
1998 CAREC 9811479 Belize 3 JN379504
2001 CAREC0106464 Barbados 3 JN379488
2001 CAREC0201394 Antigua 3 JN379489
2002 CAREC0201402 St Vincent and the Grenadines 3 JN379490
2002 CAREC0201710 St Vincent and the Grenadines 3 JN379491
2002 CAREC0106464 Barbados 3 JN379492
2002 CAREC0202137 Trinidad and Tobago 3 JN379512
2002 CAREC020213 Trinidad and Tobago 3 JN379496
2002 CAREC0202139 Trinidad and Tobago 3 JN379493
2002 CAREC0202259 Trinidad and Tobago 3 JN379494
2002 CAREC0202260 Trinidad and Tobago 3 JN379505
2002 CAREC0202290 Grenada 3 JN379495
2002 CAREC0202314 Grenada 3 JN379506
2002 CAREC0202329 Grenada 3 JN379507
2003 CAREC0301734 Barbados 3 JN379497
2003 CAREC0302290 Grenada 3 JN379498
2003 CAREC0306149 Trinidad and Tobago 3 JN379508
2003 CAREC0310367 Trinidad and Tobago 3 JN379499
2004 CAREC0400408 Barbados 3 JN379500
2004 CAREC0400409 Barbados 3 JN379509
2004 CAREC0414035 Belize 3 JN379510
2004 CAREC0414066 Belize 3 JN379511
2005 CAREC0508129 Suriname 3 JN379501
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Material online). DENV-2 Asian-American genotype and
DENV-4 genotype II sequences (the genotypes currently
circulating in the Americas) were also obtained from
GenBank and similarly prepared. In order to prevent over-
representation of come countries, data sets were down-
sampled to no more than five sequences per country
per year. Sequence genotypes were confirmed through
maximum likelihood tree estimation using a genotype ref-
erence alignment (data not shown). All sequences were
confirmed as nonrecombinant using the Recombination
Detection Program (RDP) v3 (Martin et al. 2005) and Ge-
netic algorithms for recombination detection program
(Pond and Frost 2005). Additionally, using the programs
Datamonkey and HyPhy v0.99 (Pond et al. 2005), we con-
firmed that there was no evidence for site-specific positive
selection in the data sets (at the P5 0.05 significance level).
Together, the four data sets represent 35 countries and
a time period covering 1977–2009 (available from the au-
thors on request).
Evolutionary Rates, Population Dynamics, and
Spatial Diffusion
Nucleotide substitution rates, divergence times, spatial dif-
fusion rates (i.e., rate at which viral lineages move among
sampled locations), and demographic histories were jointly
estimated from the date- and location-stamped DENV se-
quences using a Bayesian approach implemented in the
Markov chain Monte Carlo (MCMC) inference framework
of the BEAST v1.6.1 software package (Drummond and
Rambaut 2007; Lemey et al. 2009), This program uses
Bayesian MCMC methods to integrate across all plausible
tree topologies and thereby estimate evolutionary param-
eters while taking into account statistical uncertainty
arising from both phylogenetic inference and the spatial
diffusion process. Analyses were carried out using a general
time reversible (GTR) model with a discretized gamma-
distributed across-site rate variation (GTR þ C4) substitu-
tion model, a Bayesian skyride plot (BSP) coalescent model
(Drummond et al. 2005) and both a strict molecular clock
model and a relaxed (uncorrelated lognormal) molecular
clock model (Drummond et al. 2006).
Demographic histories were illustrated using BSPs (Minin
et al. 2008), which show temporal changes in the mean
estimate for relative genetic diversity (Nes, where Ne is
the effective population size and s is the generation time).
To determine the viral transmission network within the
Americas, a nonreversible discrete phylogeography model
was applied to all the data sets individually, with each
country used as discrete states. To ensure statistical effi-
ciency, we employed a Bayesian stochastic search variable
selection procedure (Lemey et al. 2009), which imposes
a prior distribution on the spatial model that favors a lim-
ited number of nonzero movement rates among pairs of
locations, thus reducing the number of estimated param-
eters and identifying only those rates that are required to
explain the observed data. A truncated Poisson prior with
a mean of log 2 and an offset of K 1 (where K5 number
of discretized location states) was used. In order to ensure
adequate sampling of the parameters of the model (with
effective sample sizes for all parameters . 200), MCMC
chain was run for 100 million states, with a 10% burn-in
period (to remove nonstationarity samples), and data were
then subsampled every 10,000 states. Model comparisons
were performed using Bayes factors (BFs) (Suchard et al.
2001), which are estimated using harmonic mean estimates
of the model marginal likelihood (Newton and Raftery
1994; Suchard et al. 2003; Redelings and Suchard 2005).
Hypothesis Testing
The Bayesian phylogeographic inference framework incor-
porated into BEAST allows for testing of scenarios about
the evolutionary and phylogeographic history. We create
pairwise location matrices representing the different diffu-
sion predictors, which are used as priors for the relative rate
parameters (Talbi et al. 2010). The different diffusion
predictors explored were
 Equal rates: spatial diffusion model that assumes equal
rates of virus movement between all countries a priori.
 Distance-informed rates: formalizes a model of more
intense virus movement between nearby locations (rates
of movement being inversely proportional to the dis-
tance between locations). Two different measures of
distance were used: GeoDistance (log of the great-circle
distance between centroids of each pair of countries) and
PopDistance (log of the great-circle distance between the
largest and closest population centres between each pair
of countries).
 Air traffic informed rates: formalizes a model of more
intense virus movement between countries with more air
traffic between them (;rates of movement being pro-
portional to the number of airline seats available between
each pair of countries). Data for this model were obtained
from OAG Max database and represent the airline seat
capacity in 2007.
The fit of the scenarios were assessed using BF compar-
ison, which allows for the comparison of the predictors on
each data set.
Results
Population Genetic History and Serotype
Prevalence
Figure 2 depicts the estimates of relative genetic diversity
for each genotype on the same timescale as a histogram
showing the percentage of infections confirmed by virus
isolation for each serotype in each year. The latter was de-
rived from records of virus isolations performed by the
CAREC and is used as a proxy for relative serotype preva-
lence in the absence of reliable data from all of the countries
surveyed. The census data indicate that DENV-1, which was
first reported in 1977 (fig. 1), predominated until 1979. It
was then quickly replaced in 1981 by DENV-4, which was
first reported in the region in that same year. DENV-2
Asian–American genotype, which was also first reported
in 1981, was slower to become established (Carrington
Allicock et al. · doi:10.1093/molbev/msr320 MBE
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et al. 2005) and did not dominate the virus isolations until
1986. Subsequently, there was a reversion to mainly DENV-
4 isolations between 1992 and 1994, then DENV-1 for 2
years, and DENV-2 for a year. Between 1997 and 1999,
DENV-2 was most prevalent, but there were also significant
numbers of DENV-1 and DENV-4 isolations and a gradual
increase in DENV-3, which became more prevalent from
1996. The latter predominated from 2000 to 2003, followed
by an abrupt decline in 2004.
In all cases, the initial increase in genetic diversity for
each serotype (fig. 2) began prior to the date when that
serotype was first reported. The date of first detection
of each genotype also corresponded to the times when
these viruses first accounted for the majority of isolations.
The plots suggest that the period when a genotype’s ge-
netic diversity is highest coincided with the period that se-
rotype is most prevalent in the Caribbean. Also, the
introduction and sharp increase of the genetic diversity
of DENV-3 coincided with a decline in DENV-4.
Inference of Substitution Rates and Dates of
Divergence
The posterior mean substitution rates inferred for DENV-1
to DENV-4 under the relaxed clockmodel are shown in table
2, along with the inferred date for the most recent common
ancestor (MRCA) of each genotype in the Americas. The
mean substitution rates for the four genotypes were very
similar, ranging from 7.8  104 subs/site/year to 9.9 
104 subs/site/year, with overlaps among the four pairs of
the 95% highest posterior density (HPD) intervals. The date
that the MRCA of each genotype was estimated to have ex-
isted was prior to the year that genotype was first reported
in the Americas. Only in the case of DENV-2 did the 95%
HPD intervals for the time of the MRCA include the year
of first detection.
Bayesian Phylogeography
We summarized the results of the Bayesian phylogeographic
analyses using maximum clade credibility (MCC) trees
(supplementary fig. S1, Supplementary Material online),
branches of which have been colored according to the most
probable location of the nodes subtending them. As has
been previously reported for DENV in this region (Foster
et al. 2004; Carrington et al. 2005; Araujo et al. 2009), there
is a strong signal of phylogenetic clustering according to
sample location, reflected by clades comprising of isolates
from either the mainland (South or Central America) or
island (Caribbean) locations, with few exceptions. In all cases,
the data are consistent with a single introduction of each
genotype followed by rapid spatial dispersion within the
Americas. From the estimated root state probability distri-
bution, we infer that these introductions were mostly likely
to Grenada (88%), Jamaica (66%), Nicaragua (67%), and
Dominica (39%) for DENV-1 to DENV-4, respectively (data
not shown). The countries that first reported each of these
viruses were Jamaica (Pan American Health Organization
1979), Cuba (Rico-Hesse 1990), Nicaragua and Panama (Cen-
ters for Disease Control and Prevention 1995), and St Bar-
thelemy, St Martin, and Dominica (Centers for Disease
Control and Prevention 1981), respectively (table 2).
Interactive virtual globe animations that demonstrate
the diffusion dynamics of DENV-1 to DENV-4 through time
after each introduction are available online at http://
www.phylogeography.org. These dispersal histories are
FIG. 2. Demographic history of DENV-1 to DENV-4 (a–d) circulating
in the Americas using Bayesian skyride model. The y axes of the
skyline plots represent relative genetic diversity (Nes). The x axis
represents the number of years prior to the date of the most recent
isolate in each analysis (i.e., 2007). The thick colored line is the mean
estimate, and the 95% HPD are indicated by the shaded area. Below
is a histogram (e) showing the percentage of infections confirmed
by virus isolation for each serotype in each year.
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summarized in figure 3, which shows snapshots of dispersal
patterns among countries from 1985 to 2008. The results
suggest that after DENV-1 genotype V was introduced into
Grenada in the Lesser Antilles, the virus rapidly spread to
South and Central America and then to the Greater Antil-
les. The Lesser Antilles remained the only source popula-
tion from 1973 until 1983, after which movement was also
observed from the Greater Antilles to other islands and to
nearby mainland regions. From 1985, Brazil, Venezuela,
Argentina, and then Colombia served as source popula-
tions to other mainland regions. Figure 4 shows only those
links that are statistically well supported (BF  6). The
strongest epidemiological links were between Argentina
and Paraguay, Venezuela and Colombia, and Nicaragua
and both Mexico and Belize. Grenada, the most probable
root state location for DENV-1, is involved in eight well-
supported links, mostly with other Caribbean islands.
The only other country with as many links is Trinidad
and to a lesser extent Brazil.
In the case of DENV-2 Asian–American genotype, the
results suggest that upon introduction to the Greater An-
tilles around 1979, this genotype spreads southward along
the island chain to the Lesser Antilles and northeastern
coast of South America. From 1984 onward, there was gene
flow back and forth along the island chain and between the
islands and South America. Dissemination within South
Table 2. Mean Substitution Rates and the Ages of the MRCA of Main Genotypes of DENV-1 to DENV-4 Circulating in the Americas.
Serotype MRCA (HPD) Year of First Report Root State Location Country of First Report Rates (HPD) (subs/site/year)
DENV-1 1973 1977 Grenada Jamaica 7.773 3 1024
(1970–1975) (6.528 3 1024, 9.081 3 1024)
DENV-2 1979 1981 Jamaica Cuba 8.600 3 1024
(1978–1981) (7.408 3 1024, 9.836 3 1024)
DENV-3 1992 1994 Nicaragua Nicaragua and Panama 9.851 3 1024
(1991–1993) (7.337 3 1024, 10.396 3 1024)
DENV-4 1979 1981 Dominica St Barthelemy, St Martin, and Dominica 9.712 3 1024
(1978–1980) (7.944 3 1024, 10.627 3 1024)
NOTE.—HPD—95% highest posterior density interval.
FIG. 3. Spatiotemporal dynamics of four DENV serotypes circulating in the Americas represented with snapshots of the dispersal pattern for
January 1985, 1995, 2001, and 2008. Lines represent MCC phylogeny branches projected on the surface. The intensity of the color indicates the
relative age of the dispersal pattern (darker 5 older).
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America is estimated to have begun around 1992, and after
1995, Central America became involved as a result of gene
flow from the islands. More statistically supported links
were noted for DENV-2 than for any other serotype,
and the countries with the most links were Colombia,
Dominican Republic, and Suriname and to a lesser extent
Barbados and Dominica.
The MCC phylogeny for DENV-3 genotype III suggests
that there was a single introduction into the Americas
through Nicaragua. Initially gene flow occurred northward
and southward along the mainland. From 1994, Brazil
operated as the major source population (evidenced by
the existence of Brazilian isolates scattered throughout
the tree). However, Central America (Nicaragua) was the
source of initial gene flow to the islands (Greater Antilles),
beginning in 1996. As was the case for DENV-2, the links
with the strongest statistical support were observed within
South America, Central America, and between mainland
regions and the islands, where the strongest links were seen
between Colombia and Venezuela and Paraguay with both
Brazil and Bolivia. The highest number of links was seen
from Martinique, Nicaragua, Brazil, Cuba, and Puerto Rico.
The first reports of DENV-4 genotype II in the Americas
were from St Barthelemy and St Martin, and Dominica in
1981 (Centers for Disease Control and Prevention 1981),
the latter of which was also the root location inferred
by our analysis. The phylogeographic reconstruction sug-
gests that following introduction DENV-4 was rapidly dis-
seminated to both South and Central America. The BSP for
DENV-4 (fig. 2) describes a second period of exponential
growth beginning in 1989, and the phylogeographic recon-
struction (fig. 3) suggests that Puerto Rico and Suriname
the major source population for this second wave. The
most significant links seen were between Barbados and Tri-
nidad, French Guiana and Martinique, and Ecuador and Pe-
ru. The countries with themost links are Suriname, Jamaica,
and Barbados.
Testing Spatial Diffusion Scenarios
In order to investigate the factors influencing rates of DENV
gene flow in the Americas, we explored four different sce-
narios for rates of movement among the countries repre-
sented in the data sets. These included 1) equal rates of
virus movement between all countries (serving as a refer-
ence model for comparison), 2) rates of virus movement
that were inversely proportional to the distance between
locations (cities and countries), and 3) a model which ex-
pects rates of movement between pairs of countries to be
proportional to the number of airline seats available be-
tween them. Surprisingly, the factors dictating the diffusion
of all the circulating genotypes appear to be different, as
FIG. 4. Significant nonzero rates of movement for DENV-1 to DENV-4 (labeled a–d, respectively) as identified by Bayesian stochastic search
variable selection using a BF test. Only links with BF . 6 are shown.
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reflected by table 3. For the serotypes DENV-1 and DENV-2,
the models with the distance-based rates performed better
(had a higher marginal likelihood) than the airline-based
model or the equal rates model in all cases. For these se-
rotypes above, the model utilizing airline seat data did not
perform as well as the distance models but did perform
significantly better than the equal rates model. For the se-
rotypes DENV-3 and DENV-4, the equal rates seemed to
best describe diffusion in the region and significantly so
for DENV-4. Definitive conclusions could not be made
about DENV-1 and DENV-3, for when the different rates
were compared for each serotype, the marginal likelihoods
did not significantly differ from each other.
Discussion
In this study, we sought to elucidate the spatiotemporal
dynamics of the four main circulating serotypes of DENV
in the Americas. Our Bayesian analyses incorporated amore
realistic relaxed clock model and utilized larger and more
temporally and geographically diverse data sets than those
used the previous study (Carrington et al. 2005). The in-
ferred posterior mean substitution rates for the four sero-
types ranged from 7.8  104 subs/site/year to 9.9  104
subs/site/year, which were comparable to those obtained
in previous studies (Twiddy et al. 2003; Carrington et al.
2005; Araujo et al. 2009; Bennett et al. 2010).
Bayesian phylogeographic analyses of all four serotypes
indicate that each arose from a single introduction prior
to the first epidemiological reports of the virus in the re-
gion. For all DENV serotypes, initial growth in viral genetic
diversity occurred shortly before the period when the vi-
rus isolation data suggest an increase in incidence of that
genotype, an outcome observed previously on a more
confined spatial scale (Bennett et al. 2010). Overall, the
population genetic histories of DENV-1, DENV-2, and
DENV-4 were similar, with an increase in genetic diversity
upon introduction into the region, followed a mainte-
nance phase where genetic diversity remains more of less
constant with only gradual increases or decreases depend-
ing on the serotype. The maintenance of genetic diversity
through time—despite significant epidemic troughs and
shifts in relative prevalence—most likely results from the
spatial population structure that is established when each
genotype invades the region (Carrington et al. 2005).
DENV-3 genotype III, the last genotype to be introduced
into the region, had a different population genetic history,
with no obvious maintenance phase. As this was the sec-
ond genotype of DENV-3 to have circulated in the region,
herd immunity may have limited the rate at which this
genotype could expand in the population.
The epidemiological data used in this study were ob-
tained from virus isolations from the English-speaking Ca-
ribbean and include a selection of symptomatic cases only.
However, the pattern of fluctuating virus activity and
changes in predominant serotypes described by these data
concur with other census data from the Americas (San
Martı´n et al. 2010), which indicate that DENV-1 and
DENV-2 were the most prevalent circulating serotypes
prior to 2002, after which there was a switch to predom-
inantly DENV-2 and DENV-3, with DENV-4 detected in
a low percentage of countries during this period. These re-
sults continue to emphasize the ability of coalescent-based
models to recover information from genetic data in the
absence of sufficient epidemiological data.
With respect to spatial epidemiology, our most probable
estimates of ancestral locations matched the countries in
which serotypes were first reported in two cases (DENV-3
and DENV-4) and identified a neighboring country in one
case (DENV-2; first reported in Cuba and estimated to have
been first introduced into Jamaica). In the case of DENV-1,
Grenada was identified as the origin, although Jamaica was
the country of first report. Although the latter are relatively
far apart, they do share linguistic, historical, and thus strong
socioeconomic links. In the Americas today, levels of sur-
veillance vary considerably among countries and are very
poor in less-developed countries. Furthermore, historical
epidemiological data for some countries are nonexistent
and incidence measures collected by some countries in
the region are rough estimates, limited by the accuracy
of diagnosis, number of suspected cases confirmed, and re-
porting rates to public health agencies. For DENV-1 to
DENV-4, the MRCAs were estimated to have existed 2–
4 years, depending on the serotype, before the first
outbreaks of these serotypes were reported. This result
is consistent with a scenario in which the virus remains
undetected until number of infections or disease incidence
reaches a detection threshold, which may be quite high due
to poor surveillance in most countries in the Americas.
Also, given the length of time between the first reports
of outbreaks and the estimated MRCA, there is the possi-
bility that virus could have moved to another country
undetected.
The cocirculation of multiple serotypes and/or geno-
types in a particular region may result in complex patterns
of competition, leading to fluctuations in genotype genetic
diversity. Bennett et al. (2010) investigated the epidemic
history of DENV-4 in Puerto Rico from its introduction
in 1981–1998. Estimates of DENV-4 relative genetic diver-
sity in this study exhibited cyclical dynamics that closely
followed epidemiological estimates of prevalence, reflect-
ing a periodicity of transmission within the population
(Bennett et al. 2010). This periodicity has also been noted
in Thailand (Nisalak et al. 2003; Cummings et al. 2004) and
Singapore (Ooi et al. 2006). However, within-country var-
iation in relative genetic diversity (Mondini et al. 2009;
Bennett et al. 2010) was not observed in our analysis, which
Table 3. Marginal Likelihood Values of the Four Different Data-
Informed Models of Virus Diffusion for Each DENV Serotype.
Model (lnL)
Serotype Equal GeoDistance PopDistance Air
DENV-1 28051.366 28050.789 28049.084 28049.143
DENV-2 28830.731 28788.436 28790.572 28792.343
DENV-3 27652.318 27652.818 27652.45 27653.351
DENV-4 26391.16 26394.209 26404.984 26404.449
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is a broader region-wide study. Instead, as noted above, ge-
netic diversity in our study is maintained despite apparent
fluctuations in epidemic activity (as measured by the per-
centage of virus isolations by CAREC), a pattern previously
described for DENV-2 and DENV-4 in the Americas
(Carrington et al. 2005) by population subdivision among
locations. Clearly, the phylodynamic behavior of DENV—as
with other viruses—depends on the scale at which it is
being studied (Pybus and Rambaut 2009). With additional
sampling among the locations and over time, more fine-
scale patterns may emerge.
One would generalize that the strongest supported mi-
gration events occur mainly between neighboring coun-
tries, but several countries (i.e., Barbados, Puerto Rico,
Colombia, Suriname, Venezuela, and Brazil) had signifi-
cantly more linkages than the others and as such possibly
play the role of hubs for the dissemination of this virus on
a seasonal basis. The possibility of other confounding fac-
tors dictating the diffusion of DENV (e.g., linguistic and/or
socioeconomic relations) has been previously suggested
(Carrington et al. 2005).
The ability to integrate useful geographic and epidemi-
ological information with viral gene sequences offers new
opportunities for hypothesis testing (Lemey et al. 2009). In
our analyses, we compared four different scenarios in an
attempt to explain the level of DENV gene flow within
the Americas. Given the nature of the anthropophilic na-
ture of the urban-dwelling vector species Ae. aegypti, the
assumption one would make is that gene flow between ad-
jacent or nearby countries is more likely than between dis-
tant locales, and as a result, the distance models would
perform better. More specifically, that the PopDistance
model (which considered distances between the closest
and largest population centers) would be a better fit than
the GeoDistance model. However, the distance models
were preferred only for DENV-1 and DENV-2 and without
statistical support in the case of DENV-1.
DENV can be disseminated by infected mosquitoes or
infected humans. Ae. aegypti typically travel relatively short
distances of about 100 m, although there are reports of in-
dividuals moving up to 800m (Reiter et al. 1995; Harrington
et al. 2005). In an attempt to distinguish between human
and mosquito movement, we formalized an air-traffic
model that incorporates airline seat capacity between each
pair of countries. This model did not perform as well as the
distance-informed models but was better than the equal
rates model for DENV-1 and DENV-2. However, a major
limitation here was the fact that the seat capacity data were
from a single year, that is, 2007, whereas the genetic data
spanned 32 years. With increasing air traffic and globaliza-
tion, flight patterns will have changed considerably over
this period. Also this analysis does not consider the role
of other methods of long-distance travel in the dissemina-
tion of infected mosquitoes and humans between coun-
tries (e.g., shipping or travel by road on the mainland).
Given the historical importance of shipping in the intro-
duction of Ae. aegypti, DENV, and other arboviruses to
the Americas (Soper 1967; Halstead 1992), it would be use-
ful to investigate the role of shipping traffic in DENV dis-
semination on a hemispheric scale. However, for most of
the Caribbean islands in our data set, sufficient shipping
data were unavailable.
The marginal likelihood estimation for the majority of
the serotypes indicated either that the equal rates model
was the best fit or that no other model was a significantly
better fit than the equal rates model. The harmonic mean
approach was used for estimating the marginal likelihoods.
Although this approach is currently one of the more com-
mon approaches, there are some major limitations, where
it can lead to a strong overestimation of the marginal like-
lihood when more complex models are analyzed. To this
end, we are investigating more effective methods of
Bayesian model comparison, along with the development
of models that allow estimating and testing different
contributions of these predictors simultaneously.
Airline traffic is an important parameter that deserves
further investigation, as the air transport network has
played a key role in the global dissemination of other acute
infections, such as influenza and severe acute respiratory
syndrome (SARS) (Colizza et al. 2006; Baker et al. 2010).
Although it would not be surprising to find that air traffic
is important in the case of DENV, this approach warrants
development as it could be applied to viruses that are less
well understood in terms of the nature of their transmis-
sion cycles. Further exploration of the historical role of hu-
man movement versus mosquito movement within the
Americas, and differences between the Americas and
Southeast Asia, is essential in gaining better insights into
DENV transmission patterns and evolutionary dynamics.
Supplementary Material
Supplementary tables S1 and S2 and figure S1 are available
at Molecular Biology and Evolution online (http://
www.mbe.oxfordjournals.org/).
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